Voloridge Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Voloridge Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-329,016	Closed	-$6.63M	–	1941
2021 Q3	$6.63M	Buy	329,016 +266,797	+429%	+$7.37M	0.04%	573
2021 Q2	$2.32M	Buy	+62,219	New	+$1.91M	0.02%	938
2020 Q1	–	Sell	-43,868	Closed	-$966K	–	1510
2019 Q4	$966K	Buy	+43,868	New	+$883K	0.02%	659

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Voloridge Investment Management's DRNA Position: Q4 2021 in Review

Voloridge Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 329,016 shares — an estimated $6.63M sold.

Voloridge Investment Management first reported a position in DRNA in Q4 2019 and held it in 3 quarters. The position peaked at $6.63M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Voloridge Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Voloridge Investment Management sold 329,016 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $6.63M.
Voloridge Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
Voloridge Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $6.63M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.